Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2019-02-01

First oral add-on treatment to insulin for treatment of certain patients with type 1 diabetes

View source ↗

Summary

The EMA announced approval of the first oral add-on treatment to insulin for certain patients with type 1 diabetes, representing a new therapy option alongside …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • oral add-on treatment to insulin